Publications
Open Markets filed an amicus brief urging the Fourth Circuit to revive antitrust claims against Johnson & Johnson, arguing the company used its acquisition of biosimilar-related patents to protect its Stelara monopoly and delay lower-cost competition.
Read MoreIn this issue, we look at efforts to reconnect antitrust enforcement to the idea of “fair competition,” which aims to prevent businesses from seeking competitive advantage through actions like reducing quality or exploiting workers. We also highlight our op-ed in the New York Times on the consolidated food industry.
Read MoreThe Open Markets Institute filed an amicus brief in the U.S. Court of Appeals for the Ninth Circuit supporting Innovative Health, LLC in Innovative Health v. Biosense Webster urging the court to uphold a jury verdict finding Biosense Webster guilty of violating federal antitrust law by using its dominant position in the cardiac-mapping market to block competition from lower-cost medical device reprocessors.
Read MoreIn this issue, we explore a recent bipartisan bill calling for a break up healthcare conglomerates that own everything from insurance companies to hospitals to pharmacies. We also launched a new report urging policymakers to prepare for the bursting of the AI bubble.
Read MoreThe Open Markets Institute filed an amicus brief in the Supreme Court, urging the Court to address Merck’s alleged misrepresentations to the Food and Drug Administration to extend its monopoly in the mumps vaccine market.
Read MoreIn this issue, we explore how America’s largest utility, NextEra, used a range of hardball tactics to block a big clean energy project in New England.
Read MorePolicy counsel Tara Pincock discusses how Michigan is suing pharmacy benefit managers Express Scripts and Prime Therapeutics for an alleged price-fixing scheme that drove up drug costs, closed pharmacies, and gave ESI near-total market control in the state.
Read MoreHealthcare, transportation, and the care economy are each captured by giant corporations or private equity, resulting in higher costs and horrible service. Three new articles from Open Markets staff in the new issue of The Washington Monthly point toward solutions.
Read MoreEditorial director Anita Jain reflects on how caring for her aging father shined a light on significant gaps in America's elder care safety net.
Read MoreIndustrial policy program manager Audrey Stienon argues that before increasing federal investment in child and elder care, measures should be taken to prevent large corporations from dominating these markets and compromising service quality for working-class families.
Read MorePolicy director Phillip Longman argues that linking employer-sponsored health insurance rates to Medicare prices could significantly reduce hidden healthcare costs, thereby increasing workers' take-home pay and improving their standard of living.
Read MoreOn Monday, December 9, the Federal Trade Commission (FTC) modified a 12-year-old consent order that previously prohibited independent pharmacies in Puerto Rico from collectively bargaining with pharmacy benefit managers (PBMs) and insurers.
Read MoreIn this issue, we take a look at how the fight to rein in Big Tech giants is moving to the states as the future for antitrust enforcement remains uncertain under the incoming Trump administration and Republican-controlled Congress.
Read MoreLegal director Sandeep Vaheesan gives insight on how concentration in the electric power sector is one of the main sources to the greenhouse gas emission crisis, which in turn, contributes to frequent periods of exceptionally high temperatures, climate change, and natural disasters.
Read More
